New study aims to tailor rectal cancer therapy with cutting-edge imaging and liquid biopsy
NCT ID NCT05524012
First seen Sep 30, 2025 · Last updated May 15, 2026 · Updated 28 times
Summary
This pilot study is testing whether advanced MRI scans and blood tests can help doctors adjust treatment for people with locally advanced rectal cancer. The goal is to see if these tools can predict which patients respond well enough to avoid surgery. Forty participants will be followed during their standard pre-surgery treatment to build a better response prediction model.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED RECTAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Radiotherapy and Radiation Oncology, Jena University Hospital
Jena, Germany
Conditions
Explore the condition pages connected to this study.